Novavax’s stock slides 7% as guidance cut offsets narrower-than ...
5 days ago · Novavax Inc.’s stock fell 4% Tuesday after the company cut its full-year guidance, offsetting a narrower-than-expected third-quarter loss and better-than-expected revenue.
Novavax, Inc. (NASDAQ:NVAX) Just Reported Earnings, And …
2 days ago · Novavax, Inc. (NASDAQ:NVAX) investors will be delighted, with the company turning in some strong numbers with its latest results.Revenues were better than expected, with US$85m in revenue some 15% ...
Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq …
2 days ago · The non-qualified stock option is an option to purchase 64,150 shares of Novavax's common stock with a per share exercise price of $9.01, the closing price of Novavax's common stock on the Nasdaq ...
Novavax, Inc. Common Stock (NVAX) Stock Price, Quote, News ... - Nasdaq
Discover real-time Novavax, Inc. Common Stock (NVAX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
Novavax stock soars as FDA removes clinical hold on its COVID …
6 days ago · Investing.com -- The U.S. Food and Drug Administration (FDA) has lifted its hold on a late-stage trial for Novavax’s COVID-influenza combination and standalone flu vaccines, the company reported ...
Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data ... - Nasdaq
2 days ago · Novavax expects 2024 total revenues to be in the range of $650-$700 million, down from its previously issued guidance of $700-$800 million due to lower COVID-19 vaccine uptake in ex-U.S. markets.
U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza ... - Nasdaq
6 days ago · About Novavax Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to help protect against serious infectious diseases.
Novavax climbs as FDA lifts clinical hold on Covid, flu combo trials
6 days ago · Novavax (NASDAQ:NVAX) shares climbed 12% premarket on Monday after the U.S. FDA lifted clinical hold on the investigational new drug application for the pharma firm’s COVID-19-Influenza ...
Novavax stock falls after guidance cut (NVAX:NASDAQ)
5 days ago · Carsten Koall/Getty Images News. Novavax (NASDAQ:NVAX) shares lost ~12% in the premarket on Tuesday after the Gaithersburg, MD-based biotech, with its Q3 2024 financials, cut its full-year revenue ...
Novavax Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch
3 days ago · NVAX | Complete Novavax Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.